About Juvenile Idiopathic Arthritis
The exact causes of juvenile idiopathic arthritis (JIA) are still not fully understood. However, researchers believe that a combination of genetic and environmental factors play a role in its development. Changes in several genes, including those belonging to the human leukocyte antigen (HLA) complex, may influence the risk of developing JIA. The immune system's inflammatory response is prolonged in individuals with JIA, particularly during joint movement.
Risk factors of JIA include:
- Genetic factors: Certain genes, such as those in the HLA complex, may increase the risk of developing JIA.
- Environmental factors: While specific environmental triggers are not yet known, they may contribute to the development of JIA alongside genetic factors.
It's important to note that these risk factors do not guarantee the development of JIA. If you have concerns about your child's risk or symptoms, it is best to consult with a healthcare professional for a comprehensive evaluation.
The most common early symptoms of juvenile idiopathic arthritis (JIA) include:
- Joint pain
- Joint stiffness
- Reduced range of motion
- Warm and swollen joints
- Limping
- Redness in the affected area
- Swollen lymph nodes
As JIA progresses or becomes more severe, other common symptoms may occur, such as:
- Recurrent fevers
- Rash
- Eye inflammation (uveitis)
- Fatigue
- Dry eyes
- Blurred vision
- Loss of appetite
It's important to note that the specific symptoms can vary depending on the type of JIA. Additionally, some children with JIA may experience growth problems and skin changes, like rashes.
Other conditions may have similar symptoms. Remember, if you or your child experience any of these symptoms, it's essential to consult with a healthcare professional for an accurate diagnosis and appropriate management.
Diagnosing juvenile idiopathic arthritis (JIA) includes excluding other conditions that may be the cause of symptoms. To help diagnose JIA, health care providers commonly perform the following examinations, tests, and procedures:
- Physical exam: The health care provider will look for physical signs of JIA, such as pain and swelling in the joints.
- Lab tests: Specific lab tests, like a blood draw, may be recommended to check for markers of inflammation and to rule out other conditions.
- Imaging studies: X-rays or MRI scans may be done to assess joint damage or inflammation.
Additional examinations, tests, and procedures may include:
- Joint aspiration: This involves removing fluid from a swollen joint to analyze it for signs of inflammation or infection.
- Disease activity assessment: Health care providers may use standardized tools to assess the severity and activity of JIA, such as the Juvenile Arthritis Disease Activity Score (JADAS).
- Functional assessment: Evaluating a child's ability to perform daily activities and assessing their quality of life can provide insights into the impact of JIA.
Early clinical detection of active joint disease is crucial to prevent further physical problems, such as permanent joint damage and muscle weakness. Regular eye exams are also important for children with JIA to monitor and prevent eye inflammation-related complications.
It's important to follow up with your health care provider if your symptoms worsen or change after these examinations. They will review the results and determine the appropriate course of action.
The goals of treatment for juvenile idiopathic arthritis are as follows:
- Control inflammation
- Reduce pain and stiffness
- Prevent joint and organ damage
- Improve joint function
- Promote physical and psychosocial growth and development of children with JIA, allowing them to engage in normal activities like school, work, sports, social life, and family life.
- Achieve remission: The ultimate goal is to reach a state of little or no disease activity or symptoms.
To achieve these treatment goals, a combination of approaches is recommended:
- Medications: One or more types of medications may be used to treat JIA.
- Nonsteroidal anti-inflammatory drugs (NSAIDs) help reduce pain and swelling. These are often the first medications used for JIA. NSAIDs are available over-the-counter or by prescription. Check with the healthcare provider or read the medication use instructions carefully to determine the right dose for a child.
- Disease-modifying antirheumatic drugs (DMARDs) may be prescribed to manage pain, reduce inflammation, and help slow the progression of JIA. An example of a DMARD is methotrexate.
- Biologic response modifiers may be prescribed to help reduce inflammation and prevent joint damage. There are several types of biologic response modifiers that work on specific parts of the immune system involved with JIA.
- Corticosteroids: Pills such as prednisone may be used short term to help treat inflammation. For children with JIA, they are often used only until other medications begin to have effect. In some cases, corticosteroids may be given as a shot into a joint.
- Physical therapy: This therapy helps improve joint mobility, relieve pain, strengthen muscles, and prevent injuries during physical activities.
- Regular medical care: Frequent check-ups allow healthcare professionals to monitor treatment progress and make adjustments as needed.
It's important to note that treatment plans may vary depending on the child's age, JIA subtype, disease severity, and other factors. Consulting with a healthcare professional is crucial for personalized treatment recommendations. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.